Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2

Detalles Bibliográficos
Autores principales: Nabavi, Seyed Fazel, Habtemariam, Solomon, Clementi, Emilio, Berindan-Neagoe, Ioana, Cismaru, Cosmin Andrei, Rasekhian, Mahsa, Banach, Maciej, Izadi, Morteza, Bagheri, Mahdi, Bagheri, Mohammad Sadegh, Nabavi, Seyed Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212214/
https://www.ncbi.nlm.nih.gov/pubmed/32399097
http://dx.doi.org/10.5114/aoms.2020.94504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212214/
https://www.ncbi.nlm.nih.gov/pubmed/32399097
http://dx.doi.org/10.5114/aoms.2020.94504

Ejemplares similares